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In humans, exposure to sunlight correlates positively with skin cancer incidence, but negatively with 
hypertension and cardiovascular mortality.  Recent results indicate that ultraviolet radiation 
mobilises storage forms of nitric oxide in the skin to reduce blood pressure and modulate cardiac 
function, which may account for some of the beneficial health effects of sunlight. Possible molecular 
mechanisms involved and implications for public health advice are discussed.  
 




Humans evolved being exposed for about half of the day to the light of the sun. Nowadays, exposure 
to sunlight is actively discouraged for fear of skin cancer, and contemporary lifestyles are associated 
with long hours spent under artificial light indoors.  Besides an increasing appreciation for the 
adverse effects of these life-style related behavioural changes on our chronobiology the balance 
between the beneficial and harmful effects of sunlight on human health is the subject of 
considerable debate, in both the scientific and popular press, and the latter is of major public health 
significance.  While there is incontrovertible evidence that ultraviolet radiation (UVR) in the form of 
sunlight is a significant predisposing factor for non-melanoma and melanoma skin cancers in pale 
skinned people(1), a growing body of data suggest general health benefits brought about by 
sunlight(2). These are believed to be mediated either by melatonin or vitamin D. Melatonin is 
produced from serotonin by the pineal gland located in the centre of the brain during periods of 
darkness, and its release is suppressed as a function of the visible light intensity sensed through 
ocular photoreceptors. Vitamin D is formed by ultraviolet B (UVB)-mediated photolysis of 7-
dehydrocholesterol in the skin.  Both melatonin and vitamin D are pleiotropic hormones that exert a 
multitude of cellular effects by interacting with membrane and nuclear receptors, and receptor-
independent actions. People with more heavily pigmented skin require higher doses of UVB to 
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produce adequate amounts of vitamin D, and this may have been an evolutionary driver to the 
variation of human skin colour with latitude and intensity of solar irradiation.  Our degree of 
exposure to sunlight is easily modified by behavioural factors such as use of clothing, sunglasses and 
sun-blocking creams, and time spent outdoors.  Balancing the carcinogenic risks with the 
requirement for vitamin D has led to advice on moderating sun exposure, whilst supplementing food 
with vitamin D.  Guidance on such behaviour is part of the public health campaigns in most countries 
with Caucasian populations.  Following these suggestions we may, however, be missing out on other 
health benefits provided by natural sunlight that are less obvious and unrelated to the above 
classical mediators. 
 
Core  Hypothesis 
We here propose that many of the beneficial effects of sunlight, particularly those related to 
cardiovascular health, are mediated by mechanisms that are independent of melatonin, vitamin D 
and exposure to UVB alone.  Specifically, we suggest that the skin is a significant store of nitric oxide 
(NO)-related species that can be mobilised by sunlight and delivered to the systemic circulation to 
exert coronary vasodilator and cardioprotective as well as antihypertensive effects (Fig.1).  We 
further hypothesize that this dermal NO reservoir is a product of local production and dietary supply 
with nitrate-rich foods. 
 
Sunlight and Cardiovascular Disease 
The roots of photomedicine are ancient, dating back to the beginnings of civilization when 
heliotherapy was found to improve certain disease states. Sunlight was observed to have 
cardiovascular effects during the MRC hypertension trials of the 1970s with blood pressure being 
consistently lower in summer than winter(3). The prevalence of hypertension and mean population 
diastolic and systolic blood pressures correlate directly with latitude, being higher in populations 
living further from the equator(4). This may be due to a number of racial and environmental factors 
other than sunlight. Yet, within the UK all cause mortality (of which the major cause is ischaemic 
heart disease) correlates linearly with latitude (relative risk 1.0 at 50°N, 1.46 ± .03 at 55°N), even 
after accounting for all known risk factors, including fruit and vegetable consumption (5). Moreover, 
following migration the mortality risk changes to that of the new place of residence (6).  Seasonal 
variations in light intensity, caused by the inclination of the Earth’s rotary axis,1 are accompanied by 
seasonal variations in incidence and mortality of cardiovascular disease (CVD). Similar to stroke, 
rates of acute coronary syndromes (incl. unstable angina, acute myocardial infarction, atrial 
                                                          
1
 Contrary to common belief, the intensity of solar radiation is not governed by the distance between Earth 
and sun; paradoxically, our planet is closest to the sun in winter, not summer. 
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fibrillation, and sudden cardiac death) are highest in the winter months with shorter hours of 
daylight(7).  Temperature stress and sympathetic activation have been suggested as a cause for this, 
but the same effect is seen in countries such as Kuwait, where temperatures in winter are most 
comfortable and impose least physiological stress(8). Sunlight exposure in temperate climates is 
markedly reduced in winter not only because of the reduction in daylight hours, but also because of 
increased light-impenetrable clothing worn.  
 
Recent Findings and Possible Impact on Cardiovascular Disease Burden 
Recently, Suschek et al demonstrated that irradiation of healthy individuals with biologically relevant 
doses of UVA leads to a sustained  reduction in blood pressure(9). This is an important finding as 
small changes in population blood pressure can produce significant reductions in deaths from 
cerebral and coronary vascular disease.  The fall in mortality due to stroke, ischaemic heart disease 
and other vascular diseases is directly and linearly proportional to the degree of reduction in blood 
pressure, and a 20 mmHg lower systolic blood pressure leads to a 2-fold reduction in overall 
mortality in both men and women aged 40-69 years(10). These dramatic effects on major causes of 
morbidity and mortality highlight the benefits expected from even small UV-mediated reductions in 
blood pressure.  Besides their positive impact on the burden of disease from a human, family and 
societal perspective, moderate exposure to sunlight may also reduce the economic burden of CVD. 
The latter has been estimated to amount to €169 billion annually for the European Union (11) and 
$519 billion for hypertension, heart disease and stroke in the United States (12) (combined impact of 
healthcare costs and lost economic output in 2003). Thus, even minor reductions in blood pressure 
due to enhanced exposure to sunlight could translate into hundred thousands of person years of life 
and billions of $/€  saved every year. 
 
What Mechanisms may be Involved and what Other Effects can be Expected from Moderate 
Exposure to Sunlight?   
Nitric oxide, produced from L-arginine by nitric oxide synthase  (NOS) in the endothelium, has been 
recognized as a key vasodilator in the vascular system since the identification of EDRF as NO (13), 
and systemic inhibition of NO formation is accompanied by an immediate rise in blood pressure.  In 
vivo, NO is rapidly inactivated by reaction with oxygenated haemoglobin and reactive oxygen 
species, giving rise to the formation of nitrate (NO3
-), nitrite (NO2
-) and several reactive nitrogen 
oxide species. The short half-life of NO should prevent it from having major actions at a distance 
from its site of production, although conversion to longer-lived species with vasodilator properties is 
known to occur in the circulation(14).  Nitrite, for long considered biologically inert at low 
concentrations, is now known to not only dilate blood vessels in its own right but to also protect 
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organs against ischemia/reperfusion (I/R) damage (reviewed in (15, 16).  Haemoglobin, myoglobin, 
xanthine oxidoreductase, cytochrome P-450 and mitochondrial enzymes can all generate NO from 
nitrite, in particular under hypoxic conditions. Apart from continuous enzymatic NO production, 
blood vessels ‘photorelax’ on direct irradiation with UVA, and this effect is potentiated in the 
presence of sodium nitrite(17). Endogenous nitrite and S-nitrosothiols (RSNOs) in the vasculature 
have been shown to account for this phenomenon, and both compounds have absorption peaks 
within the UVA wavelength range (18). Similarly, UVA irradiation of skin in vitro leads to 
photodecomposition of “NO stores”  and release of NO(19). By weight, the skin is one of the largest 
organs in the body, with a surface area of around 2m2 in the average adult. All three NOS isoforms 
are expressed in the dermis and epidermis(20), and in addition to this, nitrite and NO are generated 
on the skin surface by reduction of sweat nitrate(21) and possibly by the oxidation of ammonia(22) 
(Fig.2).  The epidermis is particularly rich in cysteine-containing proteins and their sulfhydryl groups 
are readily nitrosated to form RSNOs. Nitrite, nitrate and RSNOs are found in the dermis and 
epidermis at concentrations one or two orders of magnitude higher than those in plasma (19, 23). In 
adults, skin and blood are of comparable weight and volume, and nitrite in the epidermis alone 
amounts to ~135 μmoles, while total nitrite in blood rarely exceeds 13-15 μmoles(23).  Thus, 
mobilization of only a fraction of the relatively large epidermal pool of e.g., nitrite by sunlight is likely 
sufficient to transiently increase plasma nitrite concentrations.  The exact mechanism of release and 
nature of the dermal “NO stores” is unknown (in addition to the species discussed above it may 
include metal nitrosyls such as dinitrosyl iron complexes and NO-heme species), but increases in 
systemic nitrite availability would rapidly translate into higher concentrations of nitroso products in 
blood and tissues(24), and this is likely to contribute to cytoprotection and vasodilatation. A recent 
human study has demonstrated that UVA irradiation can increase plasma nitrite levels by 40% (9). 
This is intriguing considering that in animal models a similar increase in nitrite is associated with 
cardioprotection following I/R injury(25).  Dietary nitrate intake (predominantly from green leafy 
vegetables) may provide an alternative source of nitrite. An entero-salivary circulation of nitrate 
ensures that part of this dietary nitrate is reduced to nitrite by facultative anaerobic bacteria in the 
mouth. Thus, a high nitrate meal leads to a sustained increase in circulating nitrite(26), and this 
nitrite increase is paralleled by reduction in systemic blood pressure suggesting further reduction to 
NO(27, 28). In addition to the commensal bacterial flora mammalian tissues are endowed with the 
capacity of sequential nitrate  nitrite  NO reduction(29). Skin bound NO stores are in equilibrium 
with circulating nitrite in unirradiated individuals(23), and dietary derived nitrite may therefore ‘top 
up’ the skin reservoir.  In addition, circulating nitrate may be photolysed by UVA reaching the 
superficial dermal vasculature and give rise to the formation of NO, nitrite and nitroso species (30).  
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Thus, multiple processes in the skin and in the circulation may contribute to light-induced blood 
pressure reduction and cardioprotection, with changes in nitrite and nitroso species concentrations 
playing key roles (Fig.3). Lower levels of sunlight reaching the skin during the winter season may 
translate into lower nitrite and nitroso species concentrations in the skin and circulation, and this 
may contribute to seasonal variations in CVD. Unfortunately, little is known about seasonal 
differences in NO-related species concentrations; no data is available on nitroso species variations 
and information about circulating nitrite/nitrate levels is conflicting(31, 32), possibly due to 
confounding nutritional influences. 
Even small bursts in systemic nitrite levels can have profound effects on cardiac redox status 
and trigger long-lasting changes in abundance and post-translational modification (including 
oxidation, nitrosation, nitrosylation, nitration, and phosphorylation) of a large number of 
proteins(33).  The magnitude and breadth of nitrite-induced changes to the cytosolic and 
mitochondrial cardiac proteome is rather surprising and includes enzymes involved in metabolism, 
energy production, redox regulation, contractile function, and serine/threonine kinase signaling(33) 
as well as effects on complex I of the respiratory chain(34). Some alterations are reminiscent of 
ischemic preconditioning and consistent with a cardioprotective phenotype, although the overall 
complexity of changes observed suggest involvement of additional mechanisms.  To this end, nitrite 
has recently been shown to affect T- cell function and cytokine release(35), raising the possibility 
that it may also affect inflammatory processes. Effects of nitrite and nitroso products on 
inflammation and immune cell function would be of obvious significance for CVD, and a systemic 
increase in circulating nitrite following whole body exposure to UVR may account for the well-known 
effects of sunlight on the immune system. The situation is likely to be even more complex as both, 
melatonin and vitamin D, are known to affect the formation and availability of NO at multiple levels, 
providing ample opportunity for cross-talk between these pathways. Although nitrite would seem to 
be a likely source and nitroso species possible mediators of the effects of sunlight on blood pressure, 
the processes conferring cardioprotection may well involve additional metabolic pathways and 
signalling processes. Which NO metabolite ultimately accounts for what biological effect is currently 
unclear and elucidation of the pathways involved in local and systemic responses to sunlight will 
require further investigation. Nevertheless, it would appear that enhancing the availability of NO-
related metabolites by sunlight has the potential to confer cardiovascular protective effects not 
afforded by other mediators typically associated with exposure to sunlight. Some of the effects 
described here may not be limited to the heart but provide benefit for other organ systems as well 
(Fig.3). 
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Hypothesis Testing and Outlook 
Hypertension and ischaemic heart disease are major causes of morbidity and mortality, particularly 
in northern Europe, but excessive sun exposure carries significant risks. It appears challenging to 
appropriately measure and quantify sunlight exposure, evaluate its weighted relevance compared to 
overt traditional risk factors and establish its actual relationship with vascular function and 
endothelial function. However, if proven correct, our hypothesis will have major implications for 
public health advice. If true, we would expect to find an inverse correlation between markers of sun 
exposure, such as actinic keratoses and skin cancers and prevalence of hypertension, ischaemic 
heart disease and stroke.  Such relationships can be investigated by interrogation of population 
diagnostic databases.  Differentiating the effects of sunlight on cardiovascular and hypertensive 
mortality will require careful stratification for expected confounding variables associated with 
differing sun exposure patterns, and data on these factors (e.g. smoking history, diet and social class) 
will need to be available.  At the experimental level, we need a better understanding of precisely 
how different wavelengths of the electromagnetic solar radiation interact with NO-related species 
and what the subsequent fate of the reaction products is. Of note, also near-infrared and infrared 
light, which penetrate skin to reach much deeper tissue layers compared to UV, can release NO from 
nitrosyl-heme species(36). Thus, light of various wavelengths – perhaps even visible light - may affect 
NO status, provided overall photic energy levels are sufficient for the mobilization of dermal NO 
stores. We also need to measure the dose-response relationship of sunlight’s effects on blood 
pressure and other cardiovascular parameters such as coronary and systemic vascular distensibility 
and total peripheral resistance. This and other information will be crucial to identify how much of an 
NO-related pool of mediators is required to enable sunlight to have its proposed cardiovascular 
effects, and whether this pool is skin-bound, or present in the superficial dermal vasculature. The 
stage of life at which UV exposure occurs may be significant.  Episodic sunburn in childhood is a 
particular risk factor for malignant melanoma, the most serious of the UV-related skin cancers.  The 
most marked effect of seasonal variation in blood pressure is seen in older age cohorts(3).  
Cardiovascular mortality of individuals who moved relates to the geographical destination, not the 
childhood origin of the migrant subjects(6). The adult cardiovascular system may thus be more 
susceptible to the beneficial effects of sunlight related NO release than that of children. Considering 
the demographic transition to an ageing world population with enhanced CVD risk this 
differentiation may be significant. If confirmed, it will enable public health messages to be tailored 
to cautious sunlight exposure in childhood, with increased exposure later in life, to limit the 
carcinogenic effects of sunlight on the skin early on, while allowing full benefit to be obtained from 
its cardiovascular effects later.   In conclusion, harnessing the power of the sun for our health may 
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not stop at the production of melatonin and vitamin D but include pathways under control of NO 
and nitrite/nitrate. Irrespective of the precise mechanism(s) of action, a modulation (e.g. by dietary 
measures) of the NO-related store in the skin and cautious bodily exposure to sunlight would seem 
to provide cardiovascular benefits. The future is bright – let a little sunshine into your heart. 
 





Fig. 1: Sunlight-induced export of NO bioactivity from storage forms in the skin.  
 
Fig. 2: Enzymatic and non-enzymatic sources and location of major NO-related biomolecules in the 
skin. 
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